These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 29277788)
41. Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. Ottaviani G; Gobbo M; Sturnega M; Martinelli V; Mano M; Zanconati F; Bussani R; Perinetti G; Long CS; Di Lenarda R; Giacca M; Biasotto M; Zacchigna S Am J Pathol; 2013 Dec; 183(6):1747-1757. PubMed ID: 24096076 [TBL] [Abstract][Full Text] [Related]
42. Light-emitting diode therapy in chemotherapy-induced mucositis. Sacono NT; Costa CA; Bagnato VS; Abreu-e-Lima FC Lasers Surg Med; 2008 Nov; 40(9):625-33. PubMed ID: 18951429 [TBL] [Abstract][Full Text] [Related]
43. Alteration of the redox state with reactive oxygen species for 5-fluorouracil-induced oral mucositis in hamsters. Yoshino F; Yoshida A; Nakajima A; Wada-Takahashi S; Takahashi SS; Lee MC PLoS One; 2013; 8(12):e82834. PubMed ID: 24376587 [TBL] [Abstract][Full Text] [Related]
44. Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literature. Rossi A; Rosati G; Colarusso D; Manzione L Oncology; 2003; 64(4):353-60. PubMed ID: 12759532 [TBL] [Abstract][Full Text] [Related]
45. Glutaryl Melatonin Niosome Gel for Topical Oral Mucositis: Anti- Inflammatory and Anticandidiasis. Damrongrungruang T; Panpitakkul P; Somudorn J; Sangchart P; Mahakunakorn P; Uthaiwat P; Daduang J; Panyatip P; Puthongking P; Priprem A Curr Drug Deliv; 2020; 17(3):195-206. PubMed ID: 31969103 [TBL] [Abstract][Full Text] [Related]
46. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil. Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250 [TBL] [Abstract][Full Text] [Related]
47. Macroscopic and microscopic effects of GaAIAs diode laser and dexamethasone therapies on oral mucositis induced by fluorouracil in rats. Lara RN; da Guerra EN; de Melo NS Oral Health Prev Dent; 2007; 5(1):63-71. PubMed ID: 17366763 [TBL] [Abstract][Full Text] [Related]
48. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Cheng KK; Lee V; Li CH; Goggins W; Thompson DR; Yuen HL; Epstein JB Oral Oncol; 2011 Mar; 47(3):153-62. PubMed ID: 21220206 [TBL] [Abstract][Full Text] [Related]
49. A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy. Okada T; Nakajima Y; Nishikage T; Ryotokuji T; Miyawaki Y; Hoshino A; Tokairin Y; Kawada K; Nagai K; Kawano T Asia Pac J Clin Nutr; 2017 Jan; 26(1):42-48. PubMed ID: 28049260 [TBL] [Abstract][Full Text] [Related]
50. Topical Melatonin Niosome Gel for the Treatment of 5-FU-Induced Oral Mucositis in Mice. Uthaiwat P; Daduang J; Priprem A; Settasatian C; Chio-Srichan S; Lee YC; Mahakunakorn P; Boonsiri P Curr Drug Deliv; 2021; 18(2):199-211. PubMed ID: 32484102 [TBL] [Abstract][Full Text] [Related]
51. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model. Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W Biomed Pharmacother; 2010 Nov; 64(9):589-93. PubMed ID: 20888173 [TBL] [Abstract][Full Text] [Related]
52. Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic Analysis. Chang CT; Hsiang CY; Ho TY; Wu CZ; Hong HH; Huang YF PLoS One; 2015; 10(8):e0135102. PubMed ID: 26266941 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized controlled trial. Katrancı N; Ovayolu N; Ovayolu O; Sevinc A Eur J Oncol Nurs; 2012 Sep; 16(4):339-44. PubMed ID: 21911313 [TBL] [Abstract][Full Text] [Related]
54. Topical application of royal jelly has a healing effect for 5-fluorouracil-induced experimental oral mucositis in hamsters. Suemaru K; Cui R; Li B; Watanabe S; Okihara K; Hashimoto K; Yamada H; Araki H Methods Find Exp Clin Pharmacol; 2008 Mar; 30(2):103-6. PubMed ID: 18560624 [TBL] [Abstract][Full Text] [Related]
55. [Usefulness of antimycotic agents (itraconazole) in chemotherapy-induced mucositis of breast cancer patients]. Tsuyuki S; Kawaguchi K; Kawata Y; Yamaguchi A; Kanazawa A; Sugitatsu M; Kono Y Gan To Kagaku Ryoho; 2012 Sep; 39(9):1369-73. PubMed ID: 22996771 [TBL] [Abstract][Full Text] [Related]
58. NCCN Task Force Report. prevention and management of mucositis in cancer care. Bensinger W; Schubert M; Ang KK; Brizel D; Brown E; Eilers JG; Elting L; Mittal BB; Schattner MA; Spielberger R; Treister NS; Trotti AM J Natl Compr Canc Netw; 2008 Jan; 6 Suppl 1():S1-21; quiz S22-4. PubMed ID: 18289497 [TBL] [Abstract][Full Text] [Related]
59. Comparative study among three different phototherapy protocols to treat chemotherapy-induced oral mucositis in hamsters. Campos L; Cruz ÉP; Pereira FS; Arana-Chavez VE; Simões A J Biophotonics; 2016 Dec; 9(11-12):1236-1245. PubMed ID: 27105906 [TBL] [Abstract][Full Text] [Related]
60. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]